7541 Molybdenum cofactor biosynthesis proteins
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 2 | 0.2 | 12× | not tested | |
| Organic nitrogen compounds | 1 | 0.3 | 3.97× | not tested | |
| Homogeneous non-metal compounds | 3 | 1.7 | 1.77× | not tested | |
| Homogeneous metal compounds | 6 | 3.9 | 1.55× | not tested | |
| Nucleosides, nucleotides, and analogues | 3 | 2.2 | 1.38× | not tested | |
| Organic oxygen compounds | 2 | 1.6 | 1.27× | not tested | |
| Lipids and lipid-like molecules | 1 | 0.9 | 1.14× | not tested | |
| Organoheterocyclic compounds | 1 | 1.2 | 0.82× | not tested | |
| Organic acids and derivatives | 1 | 1.2 | 0.82× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 14 |
| DB16833 | ADP | Adenosine disphosphate | 8 |
| DB15878 | MOO | Molybdate | 6 |
| DB03766 | PPI | Propanoic acid | 3 |
| DB00171 | ATP | ATP | 2 |
| DB03366 | — | Imidazole | 2 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 1 |
| DB06697 | D8Z | Artemether | 1 |
| DB09274 | D95 | Artesunate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 23 |
| AMP | ADENOSINE MONOPHOSPHATE | 14 |
| NAmetal | SODIUM ION | 9 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 8 |
| MOO | MOLYBDATE ION | 6 |
| CAmetal | CALCIUM ION | 5 |
| CL | CHLORIDE ION | 4 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 2 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 2 |
| MTE | PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER | 2 |
| PPI | PROPANOIC ACID | 2 |
| WO4 | TUNGSTATE(VI)ION | 2 |
| ACE | ACETYL GROUP | 1 |
| B3P | 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL | 1 |
| D8Z | Artemether | 1 |
| D95 | Artesunate | 1 |
| MNmetal | MANGANESE (II) ION | 1 |
| MOmetal | MOLYBDENUM ATOM | 1 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 1 |
| NWS | Moco-AMP | 1 |